Diana Zannino

Capecitabine, Bevacizumab, and Mitomycin in First-Line Treatment of Metastatic Colorectal Cancer: Results of the Australasian Gastrointestinal Trials Group Randomized Phase III MAX Study

Niall C. Tebbutt, Kate Wilson, Val Gebski et al. · Journal of Clinical Oncology · 2010 · 412 citations · Full text

Clinical Outcomes in Adolescents and Adults After the Fontan Procedure

Mark Dennis, Diana Zannino, Karin du Plessis et al. · Journal of the American College of Cardiology · 2018 · 213 citations

Adolescent Medicine, Patient Safety, Pediatrics +8

Estimated glomerular filtration rate and albuminuria are independent predictors of cardiovascular events and death in type 2 diabetes mellitus: the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) study

P. L. Drury, R. Ting, Diana Zannino et al. · Diabetologia · 2010 · 195 citations · Full text

Renal Function, Cardiovascular Disease, Event Lowering +8

Capecitabine Versus Classical Cyclophosphamide, Methotrexate, and Fluorouracil As First-Line Chemotherapy for Advanced Breast Cancer

Martin R. Stockler, Vernon Harvey, Prudence A. Francis et al. · Journal of Clinical Oncology · 2011 · 150 citations · Full text

Atrioventricular Valve Failure in Fontan Palliation

Gregory King, Julian Ayer, David S. Celermajer et al. · Journal of the American College of Cardiology · 2019 · 137 citations

Heart Failure, Cardiothoracic Surgery, Fontan Palliation +8